HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Benzethonium Chloride Review Urged By Lonza Before Final Monograph

This article was originally published in The Rose Sheet

Executive Summary

FDA should complete a safety review of benzethonium chloride as a Category I active ingredient for the healthcare antiseptic products monograph before finalizing the rule, chemical ingredient supplier Lonza says in a recent letter to the agency.

You may also be interested in...



Benzethonium Chloride Finished Product Studies Support Efficacy – Lonza

Safety and efficacy studies on the use of benzethonium chloride in finished product formulas support a Category I classification of the ingredient in the healthcare antiseptic monograph, chemical supplier Lonza says in a May 15 citizen petition to FDA

Benzethonium Chloride Finished Product Studies Support Efficacy – Lonza

Safety and efficacy studies on the use of benzethonium chloride in finished product formulas support a Category I classification of the ingredient in the healthcare antiseptic monograph, chemical supplier Lonza says in a May 15 citizen petition to FDA

Benzethonium Chloride Bioavailability, Toxicity Studies Planned By Lonza

The safety of benzethonium chloride in differing vehicles will be tested through a combination of in vitro dermal penetration studies and a toxicokinetic study in rats to be conducted by Lonza, Inc.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel